PF-06372222
PF-06372222 is a drug which acts as a potent and selective allosteric antagonist of both the glucagon receptor and the glucagon-like peptide-1 receptor (GLP-1).
≈ 1 min read
PF-06372222. encyclopegia.org, snapshot enwiki-001374092722. /a/pf-06372222
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
PF-06372222 is a drug which acts as a potent and selective allosteric antagonist of both the glucagon receptor and the glucagon-like peptide-1 receptor (GLP-1). It was originally developed as a potential treatment for diabetes but was unsuccessful, however it has subsequently been used as a pharmacological tool compound for the study of the GLP-1 receptor and led to the discovery of non-peptide GLP-1 agonists such as orforglipron.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1374092722 under CC BY-SA 4.0; modifications have been made.